banner
FGFR inhibitor Nintedanib esylate, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ096

FGFR inhibitor Nintedanib esylate, Purity ≥98%

Synonym: 656247-18-6; FGFR inhibitor; BIBF-1120 esylate

  • MDL: MFCD26142360
  • CAS Number: 656247-18-6
  • Compound CID: 135476717
img
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Nintedanib esylate, soluble in DMSO, water and ethanol, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FGFR. It targets FGFR1, FGFR2, FGFR3, PDGFRα, PDGFRβ, VEGFR1, VEGFR2, and VEGFR3.
Molecular Weight
649.76
Molecular Formula
C33H39N5O7S
Targets
FGFR1: 69 nM; FGFR2: 37 nM; FGFR3: 108 nM; PDGFRα: 59 nM; PDGFRβ: 65 nM; VEGFR1: 34 nM; VEGFR2: 13 nM; VEGFR3: 13 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 89 mg/mL (136.97 mM); Water: 89 mg/mL (136.97 mM); Ethanol: 4 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Nintedanib esylate is used to inhibit FGFR in research, contributing to the understanding of FGFR’s involvement in fibrotic and cancerous diseases.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0